amylin glp-1 dual agonist receptor agonism enhances the effects of liraglutide in protecting against the acute metabolic side effects of olanzapine Combined Amylin/GLP-1 pharmacotherapy to promote
Description
Why does retatrutide cause nausea if it's supposed to help with weight loss
Understanding the underlying mechanisms and implementing preventative strategiesincluding optimising protein and micronutrient intakecan significantly reduce risk
Micronutrient deficiency in obese subjects undergoing low-calorie diet
Calorie restriction with or without time-restricted eating in weight loss
Combined sodium-glucose-transporters inhibitors and glucagon-like-peptide receptor agonist compared with monotherapy improves long-term survival: A real-world registry
DOI: 10.3390/antiox9100941 Estruch, R., Ros, E., Salas-Salvado, J., et al
